Riskpilot← Back to searchSign inGet full accessPUMED AB
ABActiveOrg 5568845696Hällbygatan 4 BGeneral medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
SEK 100K
-61% vs 2023
EBITDA margin
64.3%
-69% vs 2023
Equity ratio
79.6%
Financial strength
Net profit 2024
SEK 236K
-30% vs 2023
| Revenue | SEK 100K | -61% |
| EBITDA | SEK 64K | -69% |
| Net profit | SEK 236K | -30% |
| Total assets | SEK 2M | +9% |
| Equity | SEK 1,6M | +2% |
| Employees | 0 | — |
Legal name
PUMED AB
Org number
5568845696
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
16 februari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva tjänster inom hälso- och sjukvård samt handel med värdepapper och uthyrning av fastigheter och därmed förenlig verksamhet.
Address
Hällbygatan 4 B
Email
pum@glocalnet.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 356 | 441 | 441 | 255 | 100 |
| Staff expenses | — | — | — | — | −10 |
| EBITDA | 308 | 389 | 389 | 208 | 64 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 308 | 389 | 389 | 208 | 64 |
| Net financials | 2 | 192 | 192 | 173 | 186 |
| Profit before tax | 309 | 581 | 581 | 381 | 250 |
| Tax | −67 | −87 | −87 | −45 | −15 |
| Net profit | 242 | 494 | 494 | 336 | 236 |
| Item | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 204 | 1 498 | 1 498 | 1 809 | 1 971 |
| Equity | 1 069 | 1 385 | 1 385 | 1 534 | 1 570 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 136 | 113 | 113 | 275 | 401 |
| Total debt | 136 | 113 | 113 | 275 | 401 |
EBITDA margin
64.3%
This company
15.8%
Market median
+307% vs market
20212024
Equity ratio
79.6%
This company
38.2%
Market median
+108% vs market
20212024
Return on equity
15.0%
This company
18.4%
Market median
+18% vs market
20212024
Net profit margin
235.8%
This company
8.1%
Market median
+2811% vs market
20212024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-01 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AZ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
PM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PUMED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ashraf Zia Malmström | Deputy Chief Executive Officer | 0 companies |
| Per-Erik Malmström | Deputy Chief Executive Officer | 0 companies |
| Per-Uno Malmström | Chairman | 0 companies |